FDA NDC Directory · JSON-LD · Markdown
NDC 49281-860 · VACCINE · INJECTION, SUSPENSION
| Generic name | POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED) |
|---|---|
| Labeler / Manufacturer | Sanofi Pasteur Inc. |
| Marketing category | Biologic License Application · App BLA103930 |
| Dosage form / route | INJECTION, SUSPENSION · INTRAMUSCULAR |
| Active ingredients | POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED) (40 [D'ag'U]/.5mL) POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED) (8 [D'ag'U]/.5mL) POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED) (32 [D'ag'U]/.5mL) |
| Marketing started | 19901221 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).